Malaria

First-in-Human PfSPZ-LARC2 Vaccination/CHMI

Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria

Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

Integrating the Guardian Spatial Emanator Within AVENIR II

A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines

Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria

Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali

Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults

L9LS in Women of Childbearing Potential in Mali

FocaL Mass Drug Administration for Vivax Malaria Elimination

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge

Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission

Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria

Star Homes Project 2

Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda